WHY US?

OUR PASSION REFLECTS OUR COMMITMENT TO SOCIETY TO ACCELERATE THE DEVELOPMENT OF TRANSFORMATIVE TECHNOLOGIES FOR A BETTER PLANET
OUR COMMITMENT to develop the best solutions for a healthier planet is realized in the mindful insight and guidance we provide in collaboration with our partners.

OUR EXPERIENCE driving R&D and commercial operations is extensive. We have over 80 combined years working in industry, which informs our approach to developing cutting edge genomic solutions to solve challenging problems and improve planetary health.

OUR TEAM understands how to manage the interactions required to advance technologies from concept to commercial success. We focus on connecting the technology and resources required to advance from concept to seed funded proof-of-concept data generation through series raises, development and commercial launch.
Stacks Image 1234

PRINCIPALS

THE TEAM

Stacks Image 1275
TODD BIXBY
CO-FOUNDER & CHIEF EXECUTIVE OFFICER
Biotechnology and public health professional with over 20 years experience developing, deploying and evaluating technologies applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, biofuels, and consumer products.

Multi-disciplinary expertise in M&A technology analysis, basic and applied research, new product development, project management, marketing, business development, strategic alliances, and leading teams.
Stacks Image 1289
TODD BIXBY
CO-FOUNDER &
CHIEF EXECUTIVE OFFICER
Biotechnology and public health professional with over 20 years experience developing, deploying and evaluating technologies applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, biofuels, and consumer products.

Multi-disciplinary expertise in M&A technology analysis, basic and applied research, new product development, project management, marketing, business development, strategic alliances, and leading teams.

Stacks Image 1307
RICHARD EINSTEIN, PHD
CO-FOUNDER & CHIEF TECHNOLOGY OFFICER
Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes.

Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.
Stacks Image 1317
RICHARD EINSTEIN, PHD
CO-FOUNDER &
CHIEF TECHNOLOGY OFFICER
Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes.

Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.

Stacks Image 1328
GAVIN HANEY
CO-FOUNDER & PRINCIPAL ADVISOR, COMMERCIAL STRATEGY
More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology.

Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.
Stacks Image 1337
GAVIN HANEY
CO-FOUNDER & PRINCIPAL ADVISOR,
COMMERCIAL STRATEGY
More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology.

Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.

Stacks Image 1349
DAVID SIMMS
CO-FOUNDER & PRINCIPAL ADVISOR, TECHNICAL & BUSINESS ANALYTICS
A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.
Stacks Image 1359
DAVID SIMMS
CO-FOUNDER & PRINCIPAL ADVISOR,
TECHNICAL & BUSINESS ANALYTICS
A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.

MANAGEMENT EXPERTISE

Proven track record of commercial success with over 80 years of combined experience with diagnostic and therapeutic development, as well as, first-in-class product launches
Obtained FDA approvals for molecular diagnostics (PMA, BLA, 510k, EUA), as well as, development of numerous first-in-class biotechnologies regulated by EPA and USDA
Pioneered novel companion and molecular diagnostics, in addition to applications employing genetic and genome engineering for precision medicine, public health interventions and food technologies
Experts at design and development to meet FDA, CE and ISO 9001 guidelines through research feasibility, clinical validation, manufacturing scale up and commercial product launch
Developed and validated commercial business cases for technology-based investment opportunities for biotechnology companies and the Department of Defense (DoD)
Established relationships with leaders in industry, academia, and government, in addition to subject matter experts, physician key opinion leaders and other influencers
Stacks Image 1393
Interested in investment or collaboration opportunities? Please click here or contact info@planetary-genetics.com.
Stacks Image 1236